Combination therapies for weight loss and maintenance

TW202641819APending Publication Date: 2026-10-16ZIHIPP LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114150340
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-20
Filing Date
2025-12-19
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080773_001
    Figure TWG2TA001080773_001
  • Figure TWG2TA001080773_002
    Figure TWG2TA001080773_002
  • Figure TWG2TA001080773_003
    Figure TWG2TA001080773_003
Patent Text Reader

Abstract

The present disclosure provides combinations for reducing weight and / or preventing weight gain in a subject (e.g., an obese subject) comprising three or more (e.g., three or four) of: (i) an amylin analog, (ii) a GLP-1 receptor agonist, (iii) a GIP analog, and (iv) a glucagon analog. As described herein, the combination can be administered to a subject in the same pharmaceutical composition or in separate pharmaceutical compositions (e.g., via concurrent or subsequent administration).
Need to check novelty before this filing date? Find Prior Art